EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Thrombotic complications in children with Coronavirus disease 2019 and Multisystem Inflammatory Syndrome of Childhood

Riten Kumar, Michael J Rivkin, Leslie Raffini

Journal of Thrombosis and Haemostasis · 2023-09 · 21 (9) · 2313-2326

DOI: 10.1016/j.jtha.2023.05.020 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Thrombosis and Haemostasis, 2023-09. Verfasst von Riten Kumar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dana Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA; Department of Pediatrics, Harvard Medical School, Boston…. Hauptthemen laut MEDLINE: Venous Thromboembolism, Thrombophilia, COVID-19, Thrombosis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronavirus disease 2019 (COVID-19) associated coagulopathy is multifactorial and involves inflammation driven hypercoagulability, endothelial dysfunction, platelet activation, and impaired fibrinolysis. Hospitalized adults with COVID-19 are at an increased risk of both venous thromboembolism and ischemic stroke, resulting in adverse outcomes, including increased mortality. Although COVID-19 in children follows a less severe course, both arterial and venous thromboses have been reported in hospitalized children with COVID-19. Additionally, some children develop a postinfectious, hyperinflammatory illness termed multisystem inflammatory syndrome of childhood (MIS-C), which is also associated with hypercoagulability and thrombosis. Several randomized trials have evaluated the safety and efficacy of antithrombotic therapy in adults with COVID-19, although similar pediatric data are lacking. In this narrative review, we discuss the postulated pathophysiology of COVID-19 coagulopathy and summarize principal findings of the recently completed adult trials of antithrombotic therapy. We provide an up-to-date summary of pediatric studies investigating the rate of venous thromboembolism and ischemic stroke in COVID-19 and multisystem inflammatory syndrome of childhood in addition to reviewing the findings of the single, nonrandomized pediatric trial investigating the safety of prophylactic anticoagulation. Lastly, we outline adult and pediatric consensus guidelines on the use of antithrombotic therapy in this cohort. A detailed discussion of the practical implementation and current limitations of published data will hopefully address the knowledge deficits surrounding the use of antithrombotic therapy in children with COVID-19 and generate hypotheses for future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous ThromboembolismThrombophiliaCOVID-19ThrombosisIschemic StrokeBlood Coagulation DisordersAdultSARS-CoV-2Systemic Inflammatory Response SyndromeChildFibrinolytic AgentsAnticoagulantsHumans

Stichwörter der Autor:innen

COVID-19MIS-Cpediatricsthrombosis

Substanzen

AnticoagulantsFibrinolytic Agents

Autor:innen und Institutionen

  • Dana Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: riten.kumar@childrens.harvar…
  • Department of Neurology, Stroke and Cerebrovascular Center, Boston Children's Hospital, Boston, Massachusetts, USA; Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA; Department of Pediatrics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Zitieren

APA

Kumar, R., Rivkin, M. J., & Raffini, L. (2023). Thrombotic complications in children with Coronavirus disease 2019 and Multisystem Inflammatory Syndrome of Childhood. Journal of Thrombosis and Haemostasis, 21(9), 2313-2326. https://doi.org/10.1016/j.jtha.2023.05.020

Vancouver

Kumar R, Rivkin MJ, Raffini L. Thrombotic complications in children with Coronavirus disease 2019 and Multisystem Inflammatory Syndrome of Childhood. Journal of Thrombosis and Haemostasis. 2023;21(9):2313-2326. doi:10.1016/j.jtha.2023.05.020

BibTeX
@article{Kumar2023,
  author = {Kumar, Riten and Rivkin, Michael J and Raffini, Leslie},
  title = {Thrombotic complications in children with Coronavirus disease 2019 and Multisystem Inflammatory Syndrome of Childhood},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2023},
  volume = {21},
  number = {9},
  pages = {2313--2326},
  doi = {10.1016/j.jtha.2023.05.020}
}
Kostenlos starten →